Muriel Vray
- Virology top 1%
- HIV Research and Treatment 17
- Hepatology top 2%
- Hepatitis C virus research 14
- Hepatitis Viruses Studies and Epidemiology 8
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 16
- HIV/AIDS Research and Interventions 11
- Epidemiology top 5%
- Hepatitis B Virus Studies 19
- Pneumonia and Respiratory Infections 9
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- É. EschwègeBeverley BalkauLoïc ChartierGilles PeytavinJean‐Christophe PlantierDominique CostagliolaPierre‐Marie GirardLaurence Morand‐Joubert
- Partner nations
- FranceSenegalCentral African Republic
In The Last Decade
Muriel Vray
93 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 121
- Virology 573
- Hepatology 519
- Infectious Diseases 852
- Applied Microbiology and Biotechnology 49
- Epidemiology 799
Countries citing papers authored by Muriel Vray
This map shows the geographic impact of Muriel Vray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Vray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Vray more than expected).
Fields of papers citing papers by Muriel Vray
This network shows the impact of papers produced by Muriel Vray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Vray. The network helps show where Muriel Vray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muriel Vray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 1 | |
| 8 | 2016 | 57 | |
| 9 | 2015 | 256 | |
| 10 | 2015 | 22 | |
| 11 | 2015 | 14 | |
| 12 | 2013 | 20 | |
| 13 | 2013 | 35 | |
| 14 | 2011 | 9 | |
| 15 | 2005 | 37 | |
| 16 | 2003 | 50 | |
| 17 | Food and nutritional data for a population from northern France: the Fleurbaix Laventie Ville Santé (FLVS) Study. | 1998 | 17 |
| 18 | 1995 | 4 | |
| 19 | CONCORDE - MRC/ANRS RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF IMMEDIATE AND DEFERRED ZIDOVUDINE IN SYMPTOM-FREE HIV-INFECTION | 1994 | 4 |
| 20 | 1989 | 2 |
About Muriel Vray
Muriel Vray is a scholar working on Virology, Hepatology, Infectious Diseases, Epidemiology and Endocrinology, having authored 96 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (19 papers), HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (16 papers), Hepatitis C virus research (14 papers), HIV/AIDS Research and Interventions (11 papers), Pneumonia and Respiratory Infections (9 papers), Hepatitis Viruses Studies and Epidemiology (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Virology (573 citations), Hepatology (519 citations), Infectious Diseases (852 citations), Applied Microbiology and Biotechnology (49 citations) and Epidemiology (799 citations). Muriel Vray has collaborated with scholars based in France, Senegal and Central African Republic. Frequent co-authors include É. Eschwège, Beverley Balkau, Loïc Chartier, Gilles Peytavin, Jean‐Christophe Plantier, Dominique Costagliola, Pierre‐Marie Girard, Laurence Morand‐Joubert, Yusuke Shimakawa and Jean‐Luc Meynard. Their work appears in journals such as PLoS ONE, AIDS, Vaccine, BMC Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.